FDA approves new treatment for rare type of pancreatic cancer

Posted by Food and Drug Administration--Press Releases on Friday May 6, 2011 Under News

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

Be Sociable, Share!

Comments are closed.

FDA approves new treatment for rare type of pancreatic cancer

Posted by Food and Drug Administration--Press Releases on Friday May 6, 2011 Under News

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

Be Sociable, Share!

Comments are closed.